Michelle Haggar
Endocrinology, Diabetes & Metabolism · Covington, LANPI 1770757007
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $847, 5.3 times the $161 reported in 2019. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in LA, where the typical reported total is $3,044.
Across 129 payments — averaging $24.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dexcom, Inc.$576
- Novo Nordisk$529
- Lilly USA, LLC$274
- AstraZeneca$183
- Averitas Pharma Inc.$150
- SK Life Science, Inc.$139
- plus $1K from 28 others
What the payments were for
- Food & beverage$3,193100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dexcom, Inc. | 11 | $576 |
| Novo Nordisk | 23 | $529 |
| Lilly USA, LLC | 15 | $274 |
| AstraZeneca(2 entities) | 9 | $183 |
| Averitas Pharma Inc. | 2 | $150 |
| SK Life Science, Inc. | 2 | $139 |
| Sanofi-aventis U.S. LLC | 7 | $138 |
| Amgen | 6 | $126 |
| AbbVie(2 entities) | 7 | $123 |
| Recordati_rare_diseases_inc. | 5 | $112 |
| Corcept Therapeutics | 5 | $112 |
| Xeris Pharmaceuticals, Inc. | 3 | $81 |
| Kyowa Kirin, Inc. | 4 | $71 |
| IBSA Pharma Inc. | 3 | $63 |
| Radius Health, Inc. | 3 | $60 |
| Ascendis Pharma Endocrinology Inc | 3 | $53 |
| Nevro Corp. | 2 | $46 |
| Amneal Pharmaceuticals LLC | 2 | $34 |
| Mannkind Corporation | 2 | $34 |
| Novartis | 1 | $29 |
| Rhythm Pharmaceuticals, Inc. | 1 | $25 |
| Valeritas, Inc. | 1 | $23 |
| Insulet Corporation | 1 | $20 |
| UCB, Inc. | 1 | $19 |
| Abbott | 1 | $19 |
| Ascensia Diabetes Care US Inc. | 1 | $19 |
| Neurelis, Inc. | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Bayer | 1 | $18 |
| Madrigal Pharmaceuticals | 1 | $18 |
| Soleno Therapeutics, Inc. | 1 | $15 |
| Evoke Pharma, Inc. | 1 | $14 |
| Lifescan, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM G6 TRANSMITTER$228
- Qutenza$127
- XCOPRI$117
- Wegovy$115
How this compares
$3,193 in reported general payments places this provider in the 50th percentile of 95 endocrinology, diabetes & metabolism providers in Louisiana.
See all endocrinology, diabetes & metabolism providers in Louisiana →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 18 | $18,461 |
| SynthroidLevothyroxine Sodium | 17 | $1,717 |
| UnithroidLevothyroxine Sodium | 24 | $1,210 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $274 | $18,46118 claims |
| AbbVieSynthroid | $123 | $1,71717 claims |
| Amneal Pharmaceuticals LLCUnithroid | $34 | $1,21024 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 95 endocrinology, diabetes & metabolism providers in Louisiana.
Other endocrinology, diabetes & metabolism in Covington
- Timothy GilbertBaton Rouge$985K
- Vivian FonsecaNew Orleans$658K
- Abdul KhanHammond$587K
- Marideli ScanlanMarrero$444K
- Justin FontenotLafayette$397K
- Ileana TandronSlidell$205K
- Lane FreyThibodaux$202K
- Laura Kimball RavariBossier City$165K
- Lawrence BlondeNew Orleans$142K
- Harold MillerHammond$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.